Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Contents

Current Drug Targets, Volume 17 - Number 5



Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

, 17(5): 488 - 494

Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally


DOI: 10.2174/138945011705160303154717




Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications

, 17(5): 508 - 514

Mikko O. Laukkanen and Maria Domenica Castellone


DOI: 10.2174/1389450116666151001112130



CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

, 17(5): 515 - 519

Poupak Fallahi, Alda Corrado, Andrea Di Domenicantonio, Giada Frenzilli, Alessandro Antonelli and Silvia Martina Ferrari


DOI: 10.2174/1389450115666141229153949



EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer

, 17(5): 520 - 528

Terry W. Moody, Bernardo Nuche-Berenguer, Taichi Nakamura and Robert T. Jensen


DOI: 10.2174/1389450116666150107153609






Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog